Cefpodoxime: Dosing, Duration, Contraindications, and Alternatives
Dosing Regimens
Cefpodoxime proxetil is dosed at 100-400 mg every 12 hours in adults, with specific dosing dependent on infection type and severity. 1
Adult Dosing by Indication:
- Respiratory tract infections (community-acquired pneumonia, acute bacterial exacerbation of chronic bronchitis): 200 mg every 12 hours 1
- Skin and soft tissue infections: 400 mg every 12 hours (higher doses required for adequate efficacy) 1, 2
- Uncomplicated urinary tract infections: 100 mg every 12 hours 1
- Acute maxillary sinusitis: 200 mg every 12 hours 1
- Pharyngitis/tonsillitis: 100 mg every 12 hours 1
- Uncomplicated gonorrhea: 200 mg as a single dose 1
Pediatric Dosing:
- Standard dose: 8-10 mg/kg/day divided into 1-2 doses 3, 4
- Acute otitis media: 8-10 mg/kg/day in 2 divided doses 3
- Pharyngitis/tonsillitis: Can be given once daily or twice daily 5
Treatment Duration
Treatment duration varies from 5-14 days depending on the infection type, with shorter courses demonstrating equivalent efficacy for certain indications. 1
Duration by Indication:
- Pharyngitis/tonsillitis: 5 days is as effective as 10 days (superior bacteriologic eradication compared to 10 days of penicillin V) 5
- Acute otitis media: 5-10 days 3
- Respiratory tract infections: 7-14 days 1
- Skin and soft tissue infections: 7-14 days 2
- Uncomplicated UTI: 7 days 1
- Gonorrhea: Single dose 1
Important caveat: Diarrhea incidence is dose-related, occurring in 10.4% at 800 mg/day versus 5.7% at 200 mg/day, with 10% of diarrhea cases associated with C. difficile 1
Contraindications and Precautions
The primary contraindication is hypersensitivity to cephalosporins or severe penicillin allergy. 1
Key Safety Considerations:
- Renal impairment: Dose adjustment required as cefpodoxime is renally excreted; patients on hemodialysis have 50% lower drug exposure 4, 6
- Discontinuation rate: 2.7% of patients discontinued due to adverse events, with significantly higher rates at 800 mg daily versus 400 mg or 200 mg daily 1
- Pregnancy/lactation: Use standard precautions for cephalosporin class 1
Common Adverse Events (>1%):
- Diarrhea: 7% (dose-related) 1
- Nausea: 3.3% 1
- Vaginal fungal infections: 1-1.3% 1
- Abdominal pain: 1.2% 1
- Headache: 1% 1
Alternative Options
For infections where cefpodoxime is indicated, alternatives depend on the specific infection type and local resistance patterns.
Respiratory Tract Infections:
- Amoxicillin-clavulanate 875/125 mg twice daily (broader anaerobic coverage but misses MRSA) 7
- Cefuroxime axetil (similar spectrum, demonstrated equivalent efficacy) 3, 8
- Levofloxacin 500 mg daily (fluoroquinolone alternative with similar efficacy) 1
Skin and Soft Tissue Infections:
- Amoxicillin-clavulanate for animal/human bites 7
- Cefazolin 1 g every 8 hours IV for more severe infections requiring parenteral therapy 7
- Clindamycin 300 mg three times daily (good staphylococcal/streptococcal coverage) 7
Pharyngitis/Tonsillitis:
- Penicillin V remains first-line, though cefpodoxime demonstrates superior bacteriologic eradication (95% vs 78% at end of therapy) 5
- Amoxicillin standard alternative 3
Important Limitation:
Cefpodoxime susceptibility cannot be predicted by oral penicillin MIC when isolates are nonsusceptible (MIC >0.06 mg/L) for Streptococcus pneumoniae, with only 78.4% categorical agreement. 9 This is particularly relevant for community-acquired pneumonia where empiric oral cephalosporin use requires caution in areas with penicillin-nonsusceptible pneumococci.
Clinical Pearls:
- Cefpodoxime is NOT indicated for pharyngeal gonorrhea in either sex 1
- Lower bacterial eradication rates for cystitis compared to other approved agents should be considered when selecting therapy 1
- Twice-daily dosing improves compliance compared to 3-4 times daily regimens of older agents 8
- Food enhances absorption of the prodrug cefpodoxime proxetil 6